Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2738

Sort by

Sort Order Select

Journal Articles

Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial

Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stüssi, Gisela Müller, Nathan Cantoni, Richard Cathomas, Ulrich Mey, Anouk Widmer, Thorsten Zenz, Michael Gregor, Dominik Heim, Martin Andres, Rudolf Benz, Davide Rossi

Blood (2025) 145 (22): 2587–2598.

https://doi.org/10.1182/blood.2024026879

Published: 2025

Includes: Supplemental data

Journal Articles

A TIM-3–Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia

Blood (2025) 145 (22): 2599–2613.

https://doi.org/10.1182/blood.2024025440

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma

Blood (2025) 145 (22): 2614–2629.

https://doi.org/10.1182/blood.2024024781

Published: 2025

Includes: Supplemental data

Journal Articles

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma

Yakinthi Chrisochoidou, Andrea Scarpino, Salomon Morales, Shannon Martin, Sarah Bird, Yigen Li, Brian Walker, John Caldwell, Yann-Vaï Le Bihan, Charlotte Pawlyn

Blood (2025) 145 (22): 2630–2644.

https://doi.org/10.1182/blood.2024025861

Published: 2025

Includes: Supplemental data

Journal Articles

Unveiling the enigma: circulating flowerlike large B-lymphoma cells in the context of angioimmunoblastic T-cell lymphoma

Bhaumik Shah, Reza Nejati

Blood (2025) 145 (22): 2671.

https://doi.org/10.1182/blood.2025028521

Published: 2025

Journal Articles

Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin

Blood blood.2024028215.

https://doi.org/10.1182/blood.2024028215

Published: 2025

Includes: Supplemental data

Journal Articles

Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia

Blood (2025) 145 (21): 2473–2487.

https://doi.org/10.1182/blood.2024025396

Published: 2025

Includes: Supplemental data

Journal Articles

Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response

Blood (2025) 145 (21): 2460–2472.

https://doi.org/10.1182/blood.2024025355

Published: 2025

Includes: Supplemental data

Journal Articles

Up-front blinatumomab improves MRD clearance and outcome in adult Ph – B-lineage ALL: the GIMEMA LAL2317 phase 2 study

Blood (2025) 145 (21): 2447–2459.

https://doi.org/10.1182/blood.2024027500

Published: 2025

Includes: Supplemental data

Journal Articles

Lymphoid malignancies in patients with Shwachman-Diamond syndrome

Helen D. Reed, Hyunwoo Do, Edie Weller, Marian H. Harris, Christopher R. Reilly, Harrison K. Tsai, Jason E. Farrar, Bonnie W. Lau, Lauren Pommert, Christopher Gamper, Ian Atkinson, Katherine Coyne, Margret Joos, Sara Loveless, Sarah Steltz, Leah Cheng, Maggie Malsch, Kasiani Myers, Akiko Shimamura

Blood (2025) 145 (21): 2528–2532.

https://doi.org/10.1182/blood.2024026507

Published: 2025

Journal Articles

Classic hairy cell leukemia and concomitant smoldering myeloma

Husam Jum’ah, David Viswanatha

Blood (2025) 145 (21): 2533.

https://doi.org/10.1182/blood.2025028465

Published: 2025

Journal Articles

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Blood blood.2025028746.

https://doi.org/10.1182/blood.2025028746

Published: 2025

Includes: Supplemental data

Journal Articles

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

Blood blood.2025029234.

https://doi.org/10.1182/blood.2025029234

Published: 2025

Includes: Supplemental data

Journal Articles

IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening

Blood (2025) 145 (20): 2336–2352.

https://doi.org/10.1182/blood.2024027171

Published: 2025

Includes: Supplemental data

Journal Articles

Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study

Julio C. Chavez, Michael Dickinson, Javier Munoz, Matthew L. Ulrickson, Catherine Thieblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Jacob Wulff, Chad M. Williams, Joshua Winters, Ioana Kloos, Hairong Xu, Sattva S. Neelapu

Blood (2025) 145 (20): 2303–2311.

https://doi.org/10.1182/blood.2024027347

Published: 2025

Includes: Supplemental data

Journal Articles

Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma

Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Ioannis V. Kostopoulos, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Vasiliki Spiliopoulou, Magdalini Migkou, Despina Fotiou, Foteini Theodorakakou, Efstathios Kastritis, Maria Gavriatopoulou, Ourania E. Tsitsilonis, Meletios-Athanasios Dimopoulos

Blood (2025) 145 (20): 2353–2360.

https://doi.org/10.1182/blood.2024027686

Published: 2025

Journal Articles

Adult T-cell leukemia/lymphoma coexistent with immune dysregulation–associated EBV + lymphoproliferative disorder

Xuan Wang, Hongmei Yi

Blood (2025) 145 (20): 2396.

https://doi.org/10.1182/blood.2025028361

Published: 2025

Journal Articles

An Updated Understanding of Follicular Lymphoma Transformation

Erin M. Parry, Jessica Okosun

Blood blood.2024026016.

https://doi.org/10.1182/blood.2024026016

Published: 2025

Journal Articles

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia

Anna Saorin, Anna Dehler, Bartimée Galvan, Fabio Daniel Steffen, Marine Ray, Dong Lu, Xin Yu, James Kim, Aneta Drakul, Samanta Kisele, Jin Wang, Jean-Pierre Bourquin, Beat Bornhauser

Blood blood.2025028938.

https://doi.org/10.1182/blood.2025028938

Published: 2025

Includes: Supplemental data

Journal Articles

A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, Matin Salehi, Federico Jauk, Gabriela Forestieri, Simone Bocchetta, Deborah Piffaretti, Riccardo Moia, Vanessa Cristaldi, Martina di Trani, Georgia Alice Galimberti, Katia Pini, Valeria Spina, Claudia Giordano, Adalgisa Condoluci, Ilaria Romano, Salvatore Annunziata, Fabrizio Bergesio, Renzo Boldorini, Eugenio Borsatti, Pietro Bulian, Eleonora Calabretta, Stephane Chauvie, Francesco Corrado, Stefania Crisci, Marco Cuzzocrea, Rosaria De Filippi, Bernhard Gerber, Michał Kurlapski, Luigi Maria Larocca, Elisabetta Merlo, Andrea Rinaldi, Marcello Rodari, Grzegorz Romanowicz, Gian Mauro Sacchetti, Anastasios Stathis, Georg Stussi, Ilaria Zangrilli, Antonio Pinto, Luca Mazzucchelli, Valter Gattei, Jan Maciej Zaucha, Armando Santoro, Stefan Hohaus, Franco Cavalli, Alexandar Tzankov, Carmelo Carlo-Stella, Gianluca Gaidano, Luca Ceriani, Prof, Emanuele Zucca, Davide Rossi

Blood blood.2024027355.

https://doi.org/10.1182/blood.2024027355

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial

A TIM-3–Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia

Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma

Unveiling the enigma: circulating flowerlike large B-lymphoma cells in the context of angioimmunoblastic T-cell lymphoma

Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin

Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia

Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response

Up-front blinatumomab improves MRD clearance and outcome in adult Ph – B-lineage ALL: the GIMEMA LAL2317 phase 2 study

Lymphoid malignancies in patients with Shwachman-Diamond syndrome

Classic hairy cell leukemia and concomitant smoldering myeloma

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening

Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study

Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma

Adult T-cell leukemia/lymphoma coexistent with immune dysregulation–associated EBV + lymphoproliferative disorder

An Updated Understanding of Follicular Lymphoma Transformation

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia

A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only